These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8296903)

  • 21. Pharmacokinetics of new testosterone transdermal therapeutic systems in gonadotropin-releasing hormone antagonist-suppressed normal men.
    Rolf C; Gottschalk I; Behre HM; Rauch C; Thyroff U; Nieschlag E
    Exp Clin Endocrinol Diabetes; 1999; 107(1):63-9. PubMed ID: 10077358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM; Gow SM; Wu FC
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of exogenous testosterone on sexuality and mood of normal men.
    Anderson RA; Bancroft J; Wu FC
    J Clin Endocrinol Metab; 1992 Dec; 75(6):1503-7. PubMed ID: 1464655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duration of testosterone suppression after a 9.45 mg implant of the GnRH-analogue buserelin in patients with localised carcinoma of the prostate a 12-month follow-up study.
    Pettersson B; Varenhorst E; Petas A; Sandow J
    Eur Urol; 2006 Sep; 50(3):483-9. PubMed ID: 16626856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen.
    Bhasin S; Heber D; Steiner BS; Handelsman DJ; Swerdloff RS
    J Clin Endocrinol Metab; 1985 May; 60(5):998-1003. PubMed ID: 3920237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of a gonadotropin-releasing hormone antagonist on androgen-binding protein distribution and other parameters in the adult male rat.
    Danzo BJ
    Endocrinology; 1995 Sep; 136(9):4004-11. PubMed ID: 7649109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Luteinizing hormone releasing hormone analogues for contraception.
    Nillius SJ
    Clin Obstet Gynaecol; 1984 Dec; 11(3):551-72. PubMed ID: 6391776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacotherapy of paraphilias with luteinizing hormone-releasing hormone agonists.
    Briken P
    Arch Gen Psychiatry; 2002 May; 59(5):469-70; author reply 470. PubMed ID: 11982456
    [No Abstract]   [Full Text] [Related]  

  • 29. Gonadotropin-releasing hormone antagonist plus testosterone: a potential male contraceptive.
    Bremner WJ; Bagatell CJ; Steiner RA
    J Clin Endocrinol Metab; 1991 Sep; 73(3):465-9. PubMed ID: 1874925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of testosterone on mood, aggression, and sexual behavior in young men: a double-blind, placebo-controlled, cross-over study.
    O'Connor DB; Archer J; Wu FC
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2837-45. PubMed ID: 15181066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compensatory response of the luteinizing-hormone (LH)-releasing hormone (LHRH)/LH pulse generator after administration of a potent LHRH antagonist in the ram.
    Lincoln GA; Fraser HM
    Endocrinology; 1987 Jun; 120(6):2245-50. PubMed ID: 3032581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pituitary and gonadal endocrine effects and pharmacokinetics of the novel luteinizing hormone-releasing hormone antagonist teverelix in healthy men--a first-dose-in-humans study.
    Erb K; Pechstein B; Schueler A; Engel J; Hermann R
    Clin Pharmacol Ther; 2000 Jun; 67(6):660-9. PubMed ID: 10872648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gonadotropin subunit messenger RNA concentrations after blockade of gonadotropin-releasing hormone action: testosterone selectively increases follicle-stimulating hormone beta-subunit messenger RNA by posttranscriptional mechanisms.
    Paul SJ; Ortolano GA; Haisenleder DJ; Stewart JM; Shupnik MA; Marshall JC
    Mol Endocrinol; 1990 Dec; 4(12):1943-55. PubMed ID: 1707128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The biologic activity of a potent analogue of gonadotropin-releasing hormone in normal and hypogonadotropic men.
    Crowley WF; Beitins IZ; Vale W; Kliman B; Rivier J; Rivier C; McArthur JW
    N Engl J Med; 1980 May; 302(19):1052-7. PubMed ID: 6767977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of men with paraphilia with a long-acting analogue of gonadotropin-releasing hormone.
    Rösler A; Witztum E
    N Engl J Med; 1998 Feb; 338(7):416-22. PubMed ID: 9459644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The changing ratio of serum bioactive to immunoreactive follicle-stimulating hormone in normal men following treatment with a potent gonadotropin releasing hormone antagonist.
    Dahl KD; Pavlou SN; Kovacs WJ; Hsueh AJ
    J Clin Endocrinol Metab; 1986 Sep; 63(3):792-4. PubMed ID: 3090097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of estrogen in the modulation of pituitary sensitivity of LRF (luteinizing hormone-releasing factor) in men.
    Wang CF; Lasley BL; Yen SS
    J Clin Endocrinol Metab; 1975 Jul; 41(1):41-3. PubMed ID: 1097463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pubertal development in the male pig: effects of treatment with a long-acting gonadotropin-releasing hormone agonist on plasma luteinizing hormone, follicle stimulating hormone and testosterone.
    Trudeau VL; Meijer JC; Erkens JH; van de Wiel DF; Wensing CJ
    Can J Vet Res; 1992 Apr; 56(2):102-9. PubMed ID: 1534270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of simultaneous gonadotropin-releasing hormone agonist and testosterone treatment on spermatogenesis and potential fertilizing capacity in male monkeys.
    Mann DR; Gould KG; Smith MM; Duffey T; Collins DC
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1215-24. PubMed ID: 3316265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study of the endocrine manifestations of hepatic cirrhosis.
    Baker HW; Burger HG; de Kretser DM; Dulmanis A; Hudson B; O'Connor S; Paulsen CA; Purcell N; Rennie GC; Seah CS; Taft HP; Wang C
    Q J Med; 1976 Jan; 45(177):145-78. PubMed ID: 769039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.